Therapeutic potential of the proteasome inhibitor bortezomib on titanium particle-induced inflammation in a murine model

Inflammation

Volumn 35, Issue 3, 2012, Pages 905-912

  Mao, Xin ^a   Pan, Xiaoyun ^a   Cheng, Tao ^a   Zhang, Xianlong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Air pouch; Aseptic loosening; Bortezomib; NF B; Particle

Indexed keywords

BETA ACTIN; BORTEZOMIB; I KAPPA B ALPHA; INTERLEUKIN 1BETA; PROTEASOME; TITANIUM; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HISTOLOGY; INFLAMMATION; MOUSE; NONHUMAN; PROSTHESIS LOOSENING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BORONIC ACIDS; FEMALE; I-KAPPA B KINASE; INFLAMMATION; INFLAMMATION MEDIATORS; JOINT PROSTHESIS; MICE; MICE, INBRED BALB C; NF-KAPPA B; OSTEOLYSIS; PROSTHESIS FAILURE; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; RANDOM ALLOCATION; TITANIUM; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS;

EID: 84863795497     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9392-7     Document Type: Article

References (30)

1. Daniel, J., P. Pynsent, and D. McMinn. 2004. Metal-on-metal resurfacing of the hip in patients under the age of 55 years with osteoarthritis. Journal of Bone and Joint Surgery. British Volume 86(2): 177-184. (Pubitemid 38386853)
2. Sundfeldt, M., L.V. Carlsson, C.B. Johansson, P. Thomsen, and C. Gretzer. 2006. Aseptic loosening, not only a question of wear: A review of different theories. Acta Orthopaedica 77(2): 177-197.
3. Mabilleau, G., Y.M. Kwon, H. Pandit, D.W. Murray, and A. Sabokbar. 2008. Metal-on-metal hip resurfacing arthroplasty: A review of periprosthetic biological reactions. Acta Orthopaedica 79(6): 734-747.
4. Purdue, P.E., P. Koulouvaris, B.J. Nestor, and T.P. Sculco. 2006. The central role of wear debris in periprosthetic osteolysis. HSS Journal 2(2): 102-113. (Pubitemid 44328104)
5. Ingham, E., and J. Fisher. 2005. The role of macrophages in osteolysis of total joint replacement. Biomaterials 26(11): 1271-1286. (Pubitemid 39314501)
6. Ren, W., X.H. Li, B.D. Chen, and P.H. Wooley. 2004. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-κB activity. Journal of Orthopaedic Research 22(1): 21-29. (Pubitemid 38035441)
7. Goodman, S.B., M. Trindade, T. Ma, M. Genovese, and R.L. Smith. 2005. Pharmacologic modulation of periprosthetic osteolysis. Clinical Orthopaedics and Related Research 430: 39-45. (Pubitemid 40096130)
8. Paramore, A., and S. Frantz. 2003. Bortezomib. Nature Reviews. Drug Discovery 2(8): 611-612.
9. Diptendu, S., L. Khanh, K. Tapas, J. Bryan, P. Thomas, B. Lionel, and P. Edward. 2006. Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-γ mechanistic insights and implications for periprosthetic osteolysis. Journal of Bone and Joint Surgery. American Volume 88(4): 788-799.
10. Wooley, P.H., R. Morren, J. Andary, S. Sud, S.Y. Yang, L. Mayton, D. Markel, A. Sieving, and S. Nasser. 2002. Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 23(2): 517-526. (Pubitemid 33051040)
11. Ren, W., D. Markel, R. Schwendener, Y. Ding, B. Wu, and P. Wooley. 2008. Macrophage depletion diminishes implant-wearinduced inflammatory osteolysis in a mouse model. Journal of Biomedical Materials Research. Part A 85(4): 1043-1051. (Pubitemid 351717973)
12. Edwards, J., A. Sedgwick, and D. Willoughby. 1981. The formation of a structure with the features of synovial lining by subcutaneous injection of air: An in vivo tissue culture system. The Journal of Pathology 134(2): 147-156. (Pubitemid 11065839)
13. Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79(1): 13-21. (Pubitemid 24309509)
14. Goldberg, A.L. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426(6968): 895-899. (Pubitemid 38056882)
15. Richardson, P.G., B. Barlogie, J. Berenson, S. Singhal, S. Jagannath, D. Irwin, S.V. Rajkumar, G. Srkalovic, M. Alsina, and R. Alexanian. 2003. A phase 2 study of bortezomib in relapsed, refractory myeloma. The New England Journal of Medicine 348 (26): 2609-2617. (Pubitemid 36741588)
16. Lee, S.W., J.H. Kim, Y.B. Park, and S.K. Lee. 2009. Bortezomib attenuates murine collagen-induced arthritis. Annals of the Rheumatic Diseases 68(11): 1761-1767.
17. Yannaki, E., A. Papadopoulou, E. Athanasiou, P. Kaloyannidis, A. Paraskeva, D. Bougiouklis, P. Palladas, M. Yiangou, and A. Anagnostopoulos. 2010. The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats. Arthritis and Rheumatism 62(11): 3277-3288.
18. Lawrence, T. 2009. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspectives in Biology 1(6): a001651.
19. Mankan, A.K., M.W. Lawless, S.G. Gray, D. Kelleher, and R. McManus. 2009. NF-κB regulation: The nuclear response. Journal of Cellular and Molecular Medicine 13(4): 631-643.
20. Karin, M., Y. Yamamoto, and Q.M. Wang. 2004. The IKK NF-κB system: A treasure trove for drug development. Nature Reviews. Drug Discovery 3(1): 17-26. (Pubitemid 38088695)
21. Jimi, E., K. Aoki, H. Saito, F. D'Acquisto, M.J. May, I. Nakamura, T. Sudo, T. Kojima, F. Okamoto, and H. Fukushima. 2004. Selective inhibition of NF-kappaB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nature Medicine 10(6): 617-624. (Pubitemid 38796853)
22. Xu, J., H.F. Wu, E.S.M. Ang, K. Yip, M. Woloszyn, M.H. Zheng, and R.X. Tan. 2009. NF-κB modulators in osteolytic bone diseases. Cytokine & Growth Factor Reviews 20(1): 7-17.
23. Jones, L.C., C. Frondoza, and D.S. Hungerford. 1999. Immunohistochemical evaluation of interface membranes from failed cemented and uncemented acetabular components. Journal of Biomedical Materials Research 48(6): 889-898.
24. Stea, S., M. Visentin, D. Granchi, G. Ciapetti, M. Donati, A. Sudanese, C. Zanotti, and A. Toni. 2000. Cytokines and osteolysis around total hip prostheses. Cytokine 12(10): 1575-1579.
25. Epstein, F.H., P.J. Barnes, and M. Karin. 1997. Nuclear factor-kappaB-a pivotal transcription factor in chronic inflammatory disease. The New England Journal of Medicine 336(15): 1066-1071. (Pubitemid 27163860)
26. Baumann, H., and J. Gauldie. 1994. The acute phase response. Immunology Today 15(2): 74-80. (Pubitemid 24049800)
27. Lin, E., S.E. Calvano, and S.F. Lowry. 2000. Inflammatory cytokines and cell response in surgery. Surgery 127(2): 117-126. (Pubitemid 30091254)
28. Cheng, T., G.Y. Zhang, C.J. Guo, and X. Zhang. 2010. Effects of NF-κB inhibitor on titanium particulate-induced inflammation in a murine model. Journal of Surgical Research 162(2): 225-230.
29. Zhou, F., X. Zhu, H. Mao, H. Yang, D. Geng, and Y. Xu. 2010. Effects of a cannabinoid receptor 2 selective antagonist on the inflammatory reaction to titanium particles in vivo and in vitro. The Journal of International Medical Research 38(6): 2023-2032.
30. Hofbauer, L., D. Lacey, C. Dunstan, T. Spelsberg, B. Riggs, and S. Khosla. 1999. Interleukin-1 [beta] and tumor necrosis factor-[alpha], but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25(3): 255-259. (Pubitemid 29406050)